These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 25871838

  • 1. Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes.
    Caramori ML, Kim Y, Goldfine AB, Moore JH, Rich SS, Mychaleckyj JC, Kirkpatrick D, Nickerson H, Krolewski AS, Mauer M.
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E876-82. PubMed ID: 25871838
    [Abstract] [Full Text] [Related]

  • 2. Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes.
    Caramori ML, Kim Y, Natarajan R, Moore JH, Rich SS, Mychaleckyj JC, Kuriyama R, Kirkpatrick D, Mauer M.
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E883-9. PubMed ID: 25901990
    [Abstract] [Full Text] [Related]

  • 3. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy.
    Gu T, Horová E, Möllsten A, Seman NA, Falhammar H, Prázný M, Brismar K, Gu HF.
    J Diabetes Complications; 2012 Jun; 26(5):393-8. PubMed ID: 22770937
    [Abstract] [Full Text] [Related]

  • 4. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D, Ma J, Brismar K, Efendic S, Gu HF.
    J Diabetes Complications; 2009 Jun; 23(4):265-72. PubMed ID: 18599322
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY, Chen LS, Zhang LC, Zhou TB.
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [Abstract] [Full Text] [Related]

  • 6. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 7. New susceptibility loci associated with kidney disease in type 1 diabetes.
    Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkilä O, Hietala K, Kytö J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkäniemi J, Rosengård-Bärlund M, Saraheimo M, Sarti C, Söderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Wadén J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM, DCCT/EDIC Research Group, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Möllsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP.
    PLoS Genet; 2012 Sep; 8(9):e1002921. PubMed ID: 23028342
    [Abstract] [Full Text] [Related]

  • 8. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
    Möllsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G.
    Ann Med; 2006 Sep; 38(7):522-8. PubMed ID: 17101543
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
    Panduru NM, Moţa E, Moţa M, Cimponeriu D, Serafinceanu C, Cheţa DM.
    Rom J Intern Med; 2010 Sep; 48(1):81-8. PubMed ID: 21180245
    [Abstract] [Full Text] [Related]

  • 10. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
    Ma J, Nordman S, Möllsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF.
    Eur J Endocrinol; 2007 Nov; 157(5):641-5. PubMed ID: 17984244
    [Abstract] [Full Text] [Related]

  • 11. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
    Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, Ritz E.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
    [Abstract] [Full Text] [Related]

  • 12. Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy.
    Morocutti A, Sethi M, Hayward A, Lee A, Viberti G.
    J Am Soc Nephrol; 1998 Jun; 9(6):1060-6. PubMed ID: 9621289
    [Abstract] [Full Text] [Related]

  • 13. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
    Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, Postmus D, Forsblom C, Groop PH, Vionnet N, Hadjadj S, Marre M, Parving HH, Rossing P, Tarnow L.
    Diabetologia; 2010 Dec; 53(12):2562-8. PubMed ID: 20711718
    [Abstract] [Full Text] [Related]

  • 14. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.
    Amor AJ, Canivell S, Oriola J, Ricart MJ, de Hollanda AM, Bosch-Comas A, Esmatjes E.
    Nefrologia; 2014 Dec; 34(2):212-5. PubMed ID: 24658196
    [Abstract] [Full Text] [Related]

  • 15. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ, Lajer M, Maestroni A, Lewis G, Tarnow L, Maestroni S, Zerbini G, Parving HH, Maxwell AP, Groop PH, Lehtonen S.
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [Abstract] [Full Text] [Related]

  • 16. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
    Monteiro MB, Thieme K, Santos-Bezerra DP, Queiroz MS, Woronik V, Passarelli M, Machado UF, Giannella-Neto D, Oliveira-Souza M, Corrêa-Giannella ML.
    Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460
    [Abstract] [Full Text] [Related]

  • 17. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy.
    Ma J, Möllsten A, Prázny M, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF.
    Diabet Med; 2006 Oct; 23(10):1093-9. PubMed ID: 16978373
    [Abstract] [Full Text] [Related]

  • 18. Caldesmon over-expression in type 1 diabetic nephropathy.
    Millioni R, Iori E, Lenzini L, Puricelli L, Caroccia B, Arrigoni G, Rossi GP, Tessari P.
    J Diabetes Complications; 2011 Oct; 25(2):114-21. PubMed ID: 20801058
    [Abstract] [Full Text] [Related]

  • 19. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
    Rubin A, Salzberg AC, Imamura Y, Grivitishvilli A, Tombran-Tink J.
    BMC Genomics; 2016 Nov 17; 17(1):936. PubMed ID: 27855634
    [Abstract] [Full Text] [Related]

  • 20. A family-based strategy to identify genes for diabetic nephropathy.
    Covic AM, Iyengar SK, Olson JM, Sehgal AR, Constantiner M, Jedrey C, Kara M, Sabbagh E, Sedor JR, Schelling JR.
    Am J Kidney Dis; 2001 Mar 17; 37(3):638-47. PubMed ID: 11228193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.